Identification and Quantification of Cytokines in Anti-VEGF Therapy and Genetic Risk Factors in Exsudative Age-related Macular Degeneration - Cytokines and Genetics in Exsudative AMD
- Conditions
- Exsudative age-related macular degeneration (AMD), cataract, macular puckerMedDRA version: 9.1Level: LLTClassification code 10015902Term: Exudative senile macular degeneration of retinaMedDRA version: 9.1Level: LLTClassification code 10007739Term: CataractMedDRA version: 9.1Level: LLTClassification code 10025417Term: Macular puckering of retina
- Registration Number
- EUCTR2006-005684-26-AT
- Lead Sponsor
- niversitätsklinik für Augenheilkunde und Optometrie, AKH Wien
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Signed informed consent, exsudative age-related macula degeneration, surgery of cataract or ocular surgery including vitrectomy
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Prior/concomitant treatment (laser therapy, vitrectomy, anti-VEGF medication, concurrent ocular inflammation, glaucoma, diabetes mellitus, malignant tumor, women capable of bearing children, intake of cortisone
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method